We are live on ! Find out more
CRL icon

Charles River Laboratories

707 hedge funds and large institutions have $17.7B invested in Charles River Laboratories in 2021 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 245 increasing their positions, 264 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more call options, than puts

Call options by funds: $105M | Put options by funds: $57.7M

66% more first-time investments, than exits

New positions opened: 106 | Existing positions closed: 64

5% more funds holding

Funds holding: 676707 (+31)

0.56% more ownership

Funds ownership: 92.91%93.47% (+0.56%)

7% less repeat investments, than reductions

Existing positions increased: 245 | Existing positions reduced: 264

8% less capital invested

Capital invested by funds: $19.3B → $17.7B (-$1.58B)

25% less funds holding in top 10

Funds holding in top 10: 2015 (-5)

Holders
707
Holders Change
+31
Holders Change %
+4.59%
% of All Funds
10.88%
Holding in Top 10
15
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-25%
% of All Funds
0.23%
New
106
Increased
245
Reduced
264
Closed
64
Calls
$105M
Puts
$57.7M
Net Calls
+$47.4M
Net Calls Change
+$15.9M
Name Holding Trade Value Shares
Change
Change in
Stake
Chevy Chase Trust
151
Chevy Chase Trust
Maryland
$11.4M -$256K -659 -2%
Toronto Dominion Bank
152
Toronto Dominion Bank
Ontario, Canada
$11.2M +$889K +2,287 +8%
Two Sigma Advisers
153
Two Sigma Advisers
New York
$11.1M +$2.56M +6,600 +29%
State of New Jersey Common Pension Fund D
154
State of New Jersey Common Pension Fund D
New Jersey
$11M +$307K +791 +3%
Russell Investments Group
155
Russell Investments Group
United Kingdom
$10.7M -$2.05M -5,282 -16%
OAM
156
Oppenheimer Asset Management
New York
$10.4M +$538K +1,386 +5%
Ameriprise
157
Ameriprise
Minnesota
$10.3M -$90.1M -231,940 -89%
Renaissance Technologies
158
Renaissance Technologies
New York
$10.2M -$5.13M -13,200 -33%
PI
159
PineBridge Investments
New York
$10.1M -$1.33M -3,428 -11%
State of Wisconsin Investment Board
160
State of Wisconsin Investment Board
Wisconsin
$9.98M -$2.36M -6,074 -19%
PHP
161
Parkman Healthcare Partners
Connecticut
$9.76M +$350K +901 +4%
Mitsubishi UFJ Trust & Banking
162
Mitsubishi UFJ Trust & Banking
Japan
$9.65M -$961K -2,474 -9%
VAS
163
Vestmark Advisory Solutions
Massachusetts
$9.57M +$1.28M +3,299 +15%
Canada Life
164
Canada Life
Manitoba, Canada
$9.38M +$859K +2,212 +10%
Mitsubishi UFJ Asset Management
165
Mitsubishi UFJ Asset Management
Japan
$9.38M +$1.28M +3,289 +15%
TC
166
TwinBeech Capital
New York
$9.23M +$5.32M +13,706 +127%
Citigroup
167
Citigroup
New York
$9.22M -$10.7M -27,480 -53%
BAM
168
Bell Asset Management
Australia
$9.2M +$3.1M +7,983 +49%
EIP
169
Epoch Investment Partners
New York
$9.18M -$3.87M -9,956 -29%
SCM
170
Sandler Capital Management
New York
$9.11M -$37.1M -95,504 -80%
US Bancorp
171
US Bancorp
Minnesota
$9.07M +$79.6K +205 +0.9%
Allianz Asset Management
172
Allianz Asset Management
Germany
$8.62M -$12.3M -31,588 -58%
FCI
173
Financial Counselors Inc
Kansas
$8.42M +$874K +2,249 +11%
Asset Management One
174
Asset Management One
Japan
$8.35M -$989K -2,545 -10%
AAM
175
Advisors Asset Management
Colorado
$8.29M +$20.2K +52 +0.2%

CRL Hedge Fund Activity: Q4 2021 in Review

707 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q4 2021, worth a combined $17.7B — down 8.2% from $19.3B a quarter earlier.

Buyers outnumbered sellers: 106 funds opened new CRL positions and 64 closed out — a net gain of 42 holders — while 245 added to existing stakes and 264 trimmed.

The largest buyer was ClearBridge Investments, adding an estimated $210M. The largest seller was Ameriprise, cutting an estimated $90.1M.

  • 707 institutional investors held Charles River Laboratories (CRL) as of Q4 2021, up from 676 in Q3 2021.
  • Funds reported $17.7B of Charles River Laboratories stock for Q4 2021, down 8.2% quarter-over-quarter.
  • 106 funds opened new Charles River Laboratories positions in Q4 2021 and 64 closed out, a net change of +42 holders.
  • The largest Charles River Laboratories buyer in Q4 2021 was ClearBridge Investments, an estimated $210M added.
  • The largest Charles River Laboratories seller in Q4 2021 was Ameriprise, an estimated $90.1M sold.

Based on aggregated 13F filings for Q4 2021.